throbber
The EMBO Journal vol.6 no.9 pp.2753-2758, 1987
`
`Polymeric immunoglobulin M is secreted by transfectants of non-
`lymphoid cells in the absence of immunoglobulin J chain
`
`We were therefore interested in determining whether non-
`lymphoid cells could assemble and secrete IgM. Whereas IgM
`is secreted by transfected plasmacytoma cells (Neuberger, 1983;
`Ochi et al., 1983; Neuberger et al., 1984), the introduction of
`vectors driving expression of immunoglobulin cDNAs into yeast
`or Escherichia coli hosts has not resulted in effective antibody
`production - problems being encountered both with efficient
`assembly and with secretion (Cabilly et al., 1983; Boss et al.,
`1984; Wood et al., 1985). It has, however, been found that IgG
`was secreted by Xenopus oocytes that had been injected with im-
`munoglobulin mRNA (Colman et al., 1982), although it is not
`
`A p
`
`SV- HSVAI
`
`rLNpVIl
`
`Cl
`
`phsp 70
`HISp
`
`Hh/P
`
`B
`
`R
`
`Bg/Sa
`
`SP6-VA
`
`amp
`
`neo
`
`B p
`
`SV- HSVI,2
`
`L V
`r NP NP '1
`
`CR_
`
`3
`
`2
`
`phsp7O
`Sp X BgI5aSt
`
`R
`
`SP6-HSVNp
`
`4 tp
`=EL--
`- sv
`POLY gpt
`A
`
`g
`
`Ha/Sc
`
`amp
`
`500 bp
`Fig. 1. Structure of plasmids. (A) Structure of pSV-HSVXl. The thin line
`denotes the pSV2neo vector. Sequences of the immunoglobulin XI light
`chain gene are stippled, the Drosophila hsp7O promoter region (phsp7O) is
`hatched, the leader exon derived from the heavy chain variable region (LNP)
`is depicted by a filled box and the open box denotes a 60 nucleotide stretch
`of the 5'-untranslated region of tk. (B) Structure of pSV-HSVIL2. The
`various DNA segments are depicted as for pSV-HSVX1 except that the vec-
`tor (thin line) is pSV2gpt. The DNA encoding the A constant region is
`derived from a cDNA encoding the CI1I,2,3 and 4 domains as well as the
`secreted tailpiece (tp). The HS-Vjt2 transcription unit uses the SV40
`polyadenylation site (SV POLY A) of pSV2gpt. The transcription start sites
`are indicated by an arrow and the probes used for ribonuclease protection
`assays (SP6-Vx and SP6-HSVNp) are also indicated; the SP6-HSVNP probe
`lacks the LNP-VNP intron. Restriction sites are abbreviated: B, BamHI; Bg,
`BglII; H, HindIII; Ha, HaeII; Hh, HhzaI; P, PstI; Sa, Sau3AI; Sc, SacI; Sp,
`SphI; St, StuI; X, XhoI. Note that not all the sites for any one enzyme are
`shown - only those relevant to plasmid or probe construction are included.
`
`2753
`
`Antonino Cattaneo and Michael S.Neuberger
`Medical Research Council Laboratory of Molecular Biology, Hills Road,
`Cambridge CB2 2QH, UK
`Communicated by C.Milstein
`Plasmids were constructed in which expression of genes en-
`coding the heavy and light chains of a hapten-specific IgM
`antibody is under control of a heat shock promoter. Glioma,
`phaeochromocytoma and other non-lymphoid cell lines
`transfected with the plasmids were able to process and secrete
`immunoglobulin following heat induction. The glioma
`transfectants were studied in detail and were shown to secrete
`polymeric IgM in a yield similar to that obtained with a
`plasmacytoma. However, the glioma IgM was not associated
`with J chain and was largely composed of pentamers and hex-
`amers. Thus, neither J chain nor other lymphoid-specific pro-
`teins are required for assembly and secretion of polymeric
`IgM although the absence of J chain may encourage hexamer
`formation.
`Key words: immunoglobulin M/J chain/secretion/glioma
`
`Introduction
`Antibodies are secreted by plasma cells, which represent the ter-
`minal stage of B cell differentiation. Whereas a plasma cell
`secretes large quantities of pentameric immunoglobulin, an IgM-
`expressing B cell contains monomeric IgM in its membrane but
`does not normally secrete antibody. The differentiation of a B
`cell into a plasma cell is not only accompanied by a large in-
`crease in the steady-state level of immunoglobulin mRNA, but
`there is also a shift from the production of mRNA for the mem-
`brane form of the heavy chain (,) to the production of the
`secreted form (us). However, whilst B cells do not on the whole
`secrete IgM, many B cells and B cell lymphomas are found to
`contain A,s mRNA and intracellular Its polypeptide (Sibley et al.,
`1980; Vassalli et al., 1980; Sidman, 1981; Rubartelli et al.,
`1983). Thus, whilst the difference in the production of secreted
`IgM by B cells and plasma cells can be in part ascribed to regula-
`tion at the level of RNA processing, it is clear that post-
`translational processes are also implicated.
`Proteins involved in the assembly and secretion of the IgM
`pentamer could obviously play a role in this regulation. A
`lymphocyte-specific enzyme that may catalyse immunoglobulin
`assembly has been identified (Roth and Koshland, 1981) but a
`more popular candidate for fulfilling a regulatory function is im-
`munoglobulin J chain (see Koshland, 1985 for a review). Im-
`munoglobulin J chain is associated with secreted IgM and IgA
`(Halpern and Koshland, 1970; Mestecky et al., 1971) and is syn-
`thesized by plasma cells [regardless of heavy chain class express-
`ed (Kaji and Parkhouse, 1974 and 1975; Mosmann et al., 1978)]
`but not by B cells (Roth et al., 1979; Lamson and Koshland,
`1984). The onset of J chain expression roughly coincides with
`the switch from membrane IgM to secreted IgM production (Roth
`et al., 1979).
`
`© IRL Press Limited, Oxford, England
`
`Genzyme Ex. 1036, pg 905
`
`

`
`A.Cattaneo and M.S.Neuberger
`
`Table I. Antibody yields from transfected cells
`
`Cell line
`
`Cell type
`
`J[HSVi2]
`C6[HSVit2/HSVXI]
`PCl2[HSVlt2/HSVXl]
`CHO[HSVi2/HSVX1]
`HeLa[HSVA2/HSVX ]
`JW1I2I2a
`
`Plasmacytoma
`Glioma
`Phaeochromocytoma
`Fibroblast
`Epithelial
`Plasmacytoma
`
`Concentration of IgM
`(lAgIml)
`0.5
`0.6
`0.4
`0.01
`0.005
`3.5
`
`aThis cell line secretes IgM constitutively; all other lines show heat-inducible
`antibody production.
`The concentration of IgM was determined by radioimmunoassay on antigen-
`coated plates using purified JWI/2/2 IgM for calibration. Cells (3 x 10 /ml
`initial concentration) were incubated at 37°C for 3 days with 1 h heat
`shocks (42.5°C) every 24 h.
`
`possible to make a meaningful comparison of the efficiency of
`the secretion from injected oocytes to that from plasma cells.
`Here, we describe experiments to determine whether mammalian
`cell lines of non-lymphoid origin can assemble and secrete
`polymeric IgM and compare the efficiency of the process to that
`obtained using a plasmacytoma host.
`
`Results
`Inducible immunoglobulin genes
`Plasmids were constructed in which transcription of the coding
`regions for the immunoglobulin heavy and light chains is under
`control of the promoter of the Drosophila hsp70 heat-shock gene.
`The plasmid for heavy-chain expression, pSV-HSVit2 (Figure
`1B), includes the bulk of the cDNA for the immunoglobulin it
`polypeptide with the hsp70 promoter at the 5' end and the SV40
`polyadenylation signal at the 3' end. The transcription unit con-
`tains a single intron (between the regions encoding the bulk of
`the leader peptide and VHDJH) and is linked to a selective
`marker, gpt. The plasmid for light chain expression, pSV-HSVX)\
`(Figure IA), includes the expressed, genomic X1 gene of the
`mouse myeloma HOPC 2020 but with the promoter and leader
`exon replaced by the hsp7O promoter/VH-leader of plasmid
`pSV-HSVlt2. The HSVXI light chain transcription unit is link-
`ed to the neo selective marker. Association of the polypeptides
`encoded by the two plasmids should yield an IgM,XI antibody
`with specificity for the hapten 4-hydroxy-3-nitrophenacetyl (NP).
`The activity of plasmid pSV-HSV,t2 in different environments
`was determined by introducing it into a number of cell lines;
`stable transfectants were screened for the expression of im-
`munoglobulin gene mRNA and protein (Table I). As shown in
`Figure 2A, three different pools of HeLa cells transfected with
`pSV-HSVXI show inducible X gene transcription; the fourth pool
`Similarly, pSV-HSV/42
`transcribes the gene constitutively.
`transfectants of the mouse plasmacytoma J558L show inducible
`transcription of the introduced heavy-chain gene (Figure 2B); the
`size of the fragment obtained in the RNase protection assays in-
`dicates that the transcripts are initiated by the hsp7O promoter.
`It was confirmed by Northern blotting that the HSV,u2 and
`HSVX1 transcripts were indeed of the expected size (data not
`shown).
`Secretion of glycosylated IgM by non-lymphoid transfectants
`Analysis of cells transfected with pSV-HSVXl revealed that most
`of these transfectants secreted X1 light chains into the culture
`supernatant. Clones of the transfected rat phaeochromocytoma
`line PC12 and of the rat glioma C6 were analysed for X polypep-
`
`2754
`
`A
`
`r.
`cmX X -J
`C -
`
`'-
`
`,
`
`HeLa[HSVXI
`.-. + - ± -- + - +
`
`,
`
`'
`
`L
`
`HS X -.
`
`*
`
`a_
`
`..
`
`m,,,
`
`..
`
`B
`
`- U)
`
`1:
`
`!1 + .-
`
`m
`
`HS/L
`
`-
`
`U
`
`gpt
`
`>
`
`lb
`
`Fig. 2. Analysis of immunoglobulin mRNA in transfectants. (A) Assay of XI
`mRNA in HeLa transfectants. Ribonuclease protection assays were carried
`out using the SP6-Vx probe and cytoplasmic RNA from four pools of HeLa
`cells stably transfected with pSV-HSVXI. RNA was prepared from cells
`before (-) and after (+) heat shock. RNA from the plasmacytoma J558L
`served as a control and an end-labelled HpaI digest of pBR322 provided
`size markers. The protected fragment (HSX) is the length of the entire V),
`exon. (B) Assay of HS-Vfi2 RNA in J558L transfectant J[HSV/42]. The
`ribonuclease protection assay was carried out on induced (+) and uninduced
`(-) cells using a probe for the 5'-end of the HS-VIL2 transcript as well as
`for gpt mRNA.
`
`tide synthesis. Whilst there was clonal variation in the amount
`of X expressed (some neo+ clones being negative for X1 expres-
`sion), it was clear from immunoprecipitation experiments that
`heat induction of many of the C6 and PC12 transfectants resulted
`in the secretion of X light chains (Figure 3A). Interestingly, the
`amount secreted by these transfectants is comparable to the
`amount of constitutive light chain secretion by the mouse
`plasmacytoma J558L (Figure 3A), despite the fact that J558L
`contains appreciably more X1 mRNA (not shown).
`In order to test whether the phaeochromocytoma and glioma
`lines were able to assemble complete immunoglobulin, we analys-
`ed biosynthetically labelled proteins of PC12 and C6 cells that
`had been transfected with both pSV-HSV/2 and pSV-HSVXl.
`The results (Figure 3B) show that heat shocking of both cell lines
`results in induction of the synthesis of it polypeptide. The it heavy
`chain is associated with XI light chain and is glycosylated as
`judged by the effect of the glycosylation inhibitor tunicamycin
`(Figure 3B).
`The C6 glioma transfectants were able to secrete the associated
`it and X polypeptides and the antibody secreted by these glioma
`transfectants was similar to that secreted by the plasmacytoma
`transfectant JWl/2/2 in that both antibodies bound the hapten
`NP (Figure 3D) and were recognized by anti-idiotypic antibodies
`
`Genzyme Ex. 1036, pg 906
`
`

`
`A
`
`+ +
`
`So
`
`CD
`
`"
`
`r1
`
`_2
`
`B
`
`-
`
`_
`
`+
`
`_1
`
`-+ -,
`
`+
`
`; _-
`
`C
`
`(0
`
`1
`
`_-+
`
`+r
`
`p-
`
`_
`
`_
`
`im
`
`Polymeric IgM secretion from non-lymphoid cells
`
`D
`
`E
`
`-
`
`C6X+
`
`_
`
`I+
`
`+ _1
`
`Anti-x
`
`Anti - i.
`(Intracellular)
`
`Ant i- ,
`(Secreted)
`
`N
`
`>>rz I
`
`)SE
`
`Ac38 Ac 146
`Anti- idiotypes
`
`Fig. 3. Immunoglobulin secretion from transfected cells before (-) or after (+) heat-shock and in the absence or presence of tunicamycin (+Tm). (A) Light
`chain secretion by J558L and C6 and by pSV-HSVXl transfectants of C6 and PC12. Samples were immunoprecipitated from culture supernatants using anti-X
`antiserum. (B) Intracellular immunoglobulin in PC12 and C6 clones that had been transfected with both heavy and light chain expression plasmids. After
`biosynthetic labelling, cytoplasmic samples were immunoprecipitated with anti-p antiserum. (C) Secretion of IgM by C6[HSVX1/HSVyI2] transfectant and by
`constitutive IgM-secreting J558L transfectant, JW1I/2/2. After biosynthetic labelling, samples from the supernatant were precipitated with anti-i antiserum. The
`high molecular weight band in this gel that is indicated by an arrow is also precipitated from untransfected C6 cells by anti-ti antibodies and reflects
`serological cross-reaction (A.C., unpublished observations). The other arrow indicates the dye-front. (D) Comparison of IgM secretion by JWI/212 (con-
`stitutive plasmacytoma expression), C6[HSVXI/HSVA2] (heat-inducible glioma transfectant) and J[HSVA2] (which is a pSV-HSVIt2 transfectant of J558L and
`is therefore a heat-inducible IgM secreter). All samples were prepared following heat shock and analysed in parallel except that only half the JW1I2/2 sample
`was loaded on the gel and an incubation of J[HSVji2] cells in the absence of heat-shock was performed for the right hand lane. IgM from culture supernatants
`was purified by adsorption onto NIPcap-Sepharose and eluted with I mM NIPcapOH. (E) Immunoprecipitation of glioma IgM with anti-idiotypic antibodies.
`Immunoglobulin in the supernatant of biosynthetically labelled C6[HSVyt2/HSVXI] cells prior to (-) or following heat shock (+) was precipitated using
`monoclonal anti-idiotypic antibody Ac38 or Ac146 (Reth et al., 1979).
`
`(Figure 3E). Furthermore, the extent of glycosylation of the it
`polypeptide secreted by the two cell types appears similar as judg-
`ed by mobility in SDS/polyacrylamide gels.
`To compare the efficiency of antibody secretion by a glioma
`transfectant to that by a plasmacytoma, we used the C6 double
`transfectant C6[HSVAt2/HSVXl] and the J558L transfectant
`J[HSVfi2], which expresses an inducible /A gene from the
`transfected pSV-HSVi2 plasmid and constitutively transcribes
`its endogenous XI gene. In both transfectants, heat shocking
`leads to induction of i synthesis in at least 80 % of the cells as
`judged by cytoplasmic immunofluorescence. Following periodic
`heat pulses, the concentration of hapten-specific IgM in the culture
`supematants was estimated by radioimmunoassay. The results
`(Table I) confirm that the level of inducible secretion is similar
`a conclusion
`in the glioma and plasmacytoma transfectants
`which is in keeping with the results of biosynthetic labelling
`(Figure 3D). However, it is worth noting that the antibody yields
`obtained from the HeLa and CHO cell transfectants were con-
`siderably lower (Table I).
`IgM secreted by glioma transfectants is polymeric and does not
`contain J chain
`Secreted IgM is produced by plasma cells as a pentameric
`(fi2L2)5 structure (Miller and Metzger, 1965a,b; Parkhouse et
`al., 1970) that is linked by disulphide bonds and contains a single,
`covalently-linked molecule of J chain polypeptide per IgM pen-
`tamer (Mestecky et al., 1971). As it has been speculated (see
`Koshland, 1985) that J chain is necessary for IgM secretion and
`as J chain expression appears to be restricted to mature cells of
`the B lymphocyte lineage (Roth et al., 1979), it was important
`to ascertain whether the IgM secreted by the glioma transfec-
`tants did, in fact, contain immunoglobulin J chain.
`
`A
`
`-Trnt
`
`-rTTl
`
`-Tnm
`
`.1
`
`_m
`
`-Tmr
`1
`
`_d
`
`T
`
`_
`
`5m
`
`)-
`
`r
`
`B
`
`43K-
`
`26K-
`
`18K-
`
`- Tm
`
`+ Tm
`
`Z-.-, >~
`Lc)
`
`,_
`3:
`
`--
`
`><-c
`-3. _S-_
`I. o _
`
`__*q
`
`_MM4W -i - Tr-r
`
`Fig. 4. Analysis for the presence of J chain polypeptide. A rabbit antiserum
`against J chain was used to precipitate J chain from biosynthetically labelled
`cell extracts that had been made in the presence or absence of tunicamycin
`(Tm) and that had been pre-cleared with anti-light and anti-heavy chain an-
`tisera and protein A sepharose. Nevertheless, it will be seen that precipita-
`tion with the anti-J chain antiserum does bring down some residual
`immunoglobulin polypeptides. (A) Rat YO myeloma cells and cells of the
`C6[HSV,t2/HSVXI] transfectant that had been heat-induced 5 h previously
`were incubated in labelling medium for 5 h. (B) JWI/2/2 cells and cells of
`the J[HSV/A2] and C6[HSVit2/HSVXI] transfectants that had been heat-
`induced 7 h previously were incubated in labelling medium for 1 h.
`
`To determine whether there was any intracellular J chain in
`C6 cells, immunoprecipitation was carried with an anti-J chain
`antiserum using cytoplasmic extracts of biosynthetically labell-
`ed cells. The results (Figure 4A and 4B) show that J chain can
`be detected in extracts of the plasmacytoma transfectants but not
`in the C6 glioma sample. Various different labelling times were
`
`2755
`
`Genzyme Ex. 1036, pg 907
`
`

`
`A.Cattaneo and M.S.Neuberger
`
`A r,
`
`.1 O ..11
`
`I..
`
`.:I:,fl-i
`
`.1.1
`
`..;. .-I
`
`),
`
`I.
`
`.-j.
`
`L
`
`I
`
`::i.
`
`p
`
`$
`
`.N.-
`lw
`
`......
`
`."
`
`'.
`
`--
`
`1'F
`
`- ---
`
`.-
`
`5,
`
`.-I
`
`il-
`
`A.)
`
`7 '.x 1.,
`...NSL. IF
`.,,;.
`"O: 1, , -.1.
`...c .: .?t::
`.,r
`0
`
`.%.%
`.
`
`H
`
`J.-
`
`.,w
`.1
`
`N
`
`p
`
`.,
`
`e
`
`;Io
`bi,
`
`-
`
`B -4._
`C-
`
`C
`
`-'ccfr.
`
`iJ r gr-;r'
`
`Ig M _-
`
`Itm
`
`Dye >-
`
`1
`
`2
`
`red ciCI g'1
`
`IgE x-
`
`IgG :-
`
`rioII-
`
`reducing
`
`Fig. 5. IgM secreted from C6 glioma transfectant is polymeric. (A) Analysis
`by sucrose gradient centrifugation. Supernatants (1 ml) from biosynthetically
`labelled C6[HSVtt2/HSVX1] (+---+), plasmacytoma IgM-secreting transfec-
`tant JW1/2/2 (o---o) or IgGI-secreting hybridoma P8.86.9 [gift of Thereza
`Imanishi] were loaded onto a gradient (15 ml) of 10-40% sucrose in PBS
`and subjected to centrifugation in a Beckman SW40 rotor at 40C for 18 h.
`Samples were collected, the refractive indices determined and anti-NP an-
`tibody measured by radioimmunoassay. The supematants from the C6 and
`J558L transfectants were analysed in parallel. (B,C) Analysis by
`polyacrylamide gel electrophoresis. Anti-NP antibody in the supematants of
`biosynthetically labelled JW1I2/2 (labelled as JW1) or of heat-induced
`C6[HSVst2/HSVXl] was purified on hapten sorbents and analysed either
`(left panel, B) after reduction on a 7.5% SDS/polyacrylamide gel or (right
`panel, C) unreduced on a 4% SDS/polyacrylamide gel made using
`N,N'-diallyltartardiamide to cross-link. The positions of the origin, IgM,
`IgE, IgG and it markers are indicated.
`
`used as it has been reported (Mosmann et al., 1978) that the half-
`life of J chain differs considerably in different cell lines. The
`detection of J chain polypeptide in the YO rat myeloma
`demonstrates that the anti-mouse J chain antiserum that was us-
`ed will indeed precipitate rat J chain - a point that needed con-
`
`2756
`
`Fig. 6. Electron micrographs of negatively stained IgM molecules purified
`on hapten sorbents from the supernatant of heat-induced C6[HSV,t2/HSVXlI
`transfectants. Different fields are shown in which both hexamers (H) and
`pentamers (P) are visible.
`
`firming as C6 is a glioma of rat origin. Not only was no J chain
`polypeptide detected in C6 cells, but it also appeared that these
`cells did not contain J chain niRNA as judged by primer exten-
`sion assays (data not shown). Furthermore, analysis of IgM
`in
`secreted by the plasmacytoma and C6 transfectants
`alkaline/urea polyacrylamide gels after reduction and alkylation
`revealed J chain to be present only in the plasmacytoma sample
`(data not shown).
`The sizes of the IgM secreted by the plasmacytoma and glioma
`transfectants were compared using both sucrose gradient cen-
`trifugation (Figure 5A) and electrophoresis through non-reducing
`SDS/polyacrylamide gels (Figure 5B). In both analyses, the IgM
`secreted by the glioma transfectant behaved exactly like the IgM
`secreted by the plasmacytoma and revealed itself to be a high
`molecular weight, covalently-associated aggregate. The resolution
`of the centrifugation and gel electrophoresis experiments was not,
`however, sufficient to demonstrate that the polymeric IgM
`secreted by the glioma transfectants was of exactly the same size
`as that produced by the plasmacytoma cells. We therefore resorted
`to an analysis of negatively stained protein samples in the elec-
`tron microscope (Figure 6). Comparison of the IgM samples
`prepared from plasmacytoma and glioma transfectants shows that
`whereas the IgM secreted by the plasmacytoma is almost ex-
`clusively pentameric, the sample prepared from the glioma
`transfectants is found to contain both cyclic hexamers and cyclic
`pentamers in approximately equal amounts. The sample prepared
`from C6 cells also contains some molecules which, at first sight,
`appear to be incompletely assembled structures. However, the
`same structures are seen in the plasmacytoma IgM sample and
`are most probably hexamers or pentamers that are not lying flat
`on the grid (see Feinstein and Munn, 1969). Analysis of IgM
`secreted from the heat-inducible plasmacytoma transfectant
`J[HSV,g2] revealed it to be exclusively pentameric, indicating
`that the presence of hexamers in the glioma sample is unlikely
`to be an artefact of heat shocking.
`
`Genzyme Ex. 1036, pg 908
`
`

`
`Finally, it is worth noting that pulse-chase experiments per-
`formed using biosynthetic labelling (not shown) revealed that the
`polymerization of the IgM molecules occurred prior to their secre-
`tion from the glioma or plasmacytoma cell.
`
`Discussion
`Several different non-lymphoid cell lines were transfected with
`immunoglobulin heavy and light chain genes whose expression
`was under control of a heat-shock promoter. Transfectants were
`obtained that showed inducible expression, demonstrating that
`non-lymphoid cells are capable of assembling, processing and
`secreting immunoglobulin. There was considerable variation in
`the yield of immunoglobulin obtained using different cell types
`as host. Whereas HeLa and CHO cells gave relatively poor yields,
`the amounts of antibody
`secreted by glioma and
`phaeochromocytoma transfectants were comparable to those ob-
`tained using a plasmacytoma host. The greater efficacy of C6
`glioma or PC12 as opposed to CHO or HeLa transfectants in
`antibody secretion does not appear to be due to a difference in
`the induction of immunoglobulin mRNA synthesis but rather may
`reflect the fact that the glioma and phaeochromocytoma are
`secretory cell types and may therefore be better equipped for the
`production of secreted immunoglobulin.
`The IgM secreted by the C6 transfectants is polymeric, not-
`withstanding the absence of immunoglobulin J chain. This was
`somewhat unexpected as it has been proposed that J chain is re-
`quired for the assembly and secretion of IgM (Koshland, 1985).
`However, assembly of polymeric IgM in the absence of J chain
`has previously been shown to occur both in vitro (Kownatzki,
`1973; Eskeland, 1974 and 1977) and in vivo (Stott, 1976)
`although in some cases the high molecular weight products have
`been shown to be non-covalently bonded (Wilde and Koshland,
`1978). In light of the results presented here, it is worth consider-
`ing what the role of J chain in plasma cells might be. It could
`be involved in catalysing the rate of IgM assembly - as has been
`suggested from in vitro experiments (A.Feinstein, personal com-
`munication) - or it could be involved in stabilizing the pen-
`tamers. Indeed, the IgM secreted by the glioma transfectants is
`part pentameric, part hexameric and it is conceivable that the
`presence of hexamers is a direct consequence of the absence of
`J chain. However, in this context, it is worth noting that whereas
`serum IgM - like the IgM secreted by the J558L transfectants
`- is pentameric,
`the IgM secreted by another mouse
`plasmacytoma (MOPC 104E) has been found to contain a very
`small proportion of hexamers, although J chain is expressed in
`this plasmacytoma (Parkhouse et al., 1970). It is interesting that
`the IgM antibody of Xenopus is exclusively hexameric (Metzger,
`1970; Parkhouse et al., 1970); it is not clear whether Xenopus
`IgM contains J chain although a polypeptide similar to it has been
`described in amphibia (Weinheimer et al., 1971).
`Therefore, in summary, it is clear that J chain is not required
`for the production of polymeric IgM in good yield from the
`glioma transfectants. It is, however, possible that the IgM secreted
`by these transfectants is deficient in some functional aspect. In-
`deed, evidence has been published that indicates a requirement
`for J chain in the selective transport of polymeric human IgM
`through secretory cells into exocrine fluids (Brandtzaeg and
`Prydz, 1984). The activity of the glioma IgM in epithelial
`transport and complement activation will be tested. Alternative-
`ly, it is possible that J chain may be involved in catalysing the
`production of IgM pentamers, as opposed to a pentamer/hex-
`amer mixture. This can be tested by introducing an inducible J
`
`Polymeric IgM secretion from non-lymphoid cells
`
`chain gene into both B cell lymphomas and into the glioma
`transfectants.
`Both PC12 and C6 cells are derived from cell types present
`in the nervous system. The fact that transfectants of both cell
`types are able to synthesize and secrete immunoglobulin means
`that it should be possible to engineer the production of specific
`antibodies in the central nervous system of transgenic organisms
`in order to perturb or modulate the activity of selected neuronal
`pathways.
`Materials and methods
`Plasmid construction
`Plasmid pSV-HSViA2 includes the HS-Vy2 transcription unit cloned into a
`derivative of pSV2gpt (Mulligan and Berg, 1981) in which the BamHI site has
`been converted to a SacI site by use of linkers. The HS-V/.t2 transcription unit
`was assembled in three parts. The promoter/transcription start region was ob-
`tained from plasmid pFl of Pelham (1982) as an EcoR-BgfIl fragment and con-
`tains the Drosophila hsp 70 promoter from an EcoRI site at the 5' end to the SalI
`site immediately 3' of the TATA where it
`is fused to the 60 nucleotide
`HaeIII-BgllI fragment of herpes simplex virus tk which includes the RNA cap
`site. The DNA encoding the leader region of the heavy chain polypeptide (LNP)
`was obtained from mouse VH gene V-47 (Neuberger, 1983) and extends from
`the Sau3AI site at the transcription start through the leader-VNP intron to a PstI
`site at codon +5 of VNP (Neuberger, 1983). The rest of the heavy chain coding
`region is derived from a cDNA clone for the heavy chain of an NP-specific an-
`tibody [pAB I1I (Bothwell et al., 1981)] and extends from the PstI site at codon
`+5 to a HaeIl site in the CQ 3'-untranslated region. After final assembly of pSV-
`HSVIs2, the Haell site at the 3' end of Cy is brought adjacent to the SacI site
`in the derivatized pSV2gpt vector. Plasmid pSV-HSVit2 is a cDNA derivative
`of pSV-HSV1tI (Mason, 1987).
`Plasmid pSV-HSVXI is based on a derivative of pSV2neo (Southern and Berg,
`1982) in which the HindlIl site has been destroyed by filling in and a new Hin-
`dIII site created by linker insertion in the BamHI site. The promoter/transcrip-
`tion start/leader region is the same as in pSV-HSVjt2 except (i) that the region
`5' of the promoter extends only as far as the SphI site, and (ii) the LNP-VNP
`intron is truncated at an HhaI site. This HhaI site in the LNP-VNP intron is fus-
`ed to a PstI site in the LX-V), intron of the expressed XI gene of the mouse
`plasmacytoma HOPC 2020 (Brack and Tonegawa, 1977), which provides the
`rest of the transcription unit.
`The probe for mapping HS-Vii2 transcripts was obtained by subcloning into
`pSP65 a fragment derived from an intronless derivative of pSV-HSVA2 that ex-
`tends from the StuI site in VNP back to the XhoI site in the hsp70 promoter. The
`probe for light chain expression was obtained by subcloning the BamHI-PstI
`Vx fragment of the HOPC 2020 light chain gene into plasmid pSP65.
`Cell lines and transfection
`Mouse plasmacytoma J558L (Oi et al., 1983), its IgM-secreting transfectant
`JW1/2/2 (Neuberger et al., 1984), rat myeloma YO (Galfre and Milstein, 1981),
`C6 rat glioma (Benda et al., 1968) and chinese hamster ovary (CHO) and HeLa
`cells were grown in DMEM containing 10% FCS whereas PC12 cells (Greene
`and Tischler, 1976) were grown in RPMI containing 10O% heat-inactivated horse
`serum and 5% FCS. The phenotype of the C6 glioma cells and its transfectants
`was confirmed by measuring receptors for nerve growth factor (NGF) (Cattaneo
`et al., 1983), fluorescent staining with antibody MC 192 (Chandler et al., 1984),
`immunoprecipitation of S100 protein (Labourdette and Mandel, 1978) and im-
`munofluorescent staining for glial fibrillar acidic protein (Raju et al., 1980). The
`PC12 cell transfectants were shown to respond to NGF. Transfection by
`spheroplast fusion was carried out as previously described (Neuberger, 1983)
`and electroporation (Neumann et al., 1982) was performed by giving four 2 kV
`pulses to a suspension of 2.5 x 107 cells in 0.5 ml PBS containing 20 Ag of
`supercoiled plasmid DNA. Transfection of J558L and C6 glioma was by
`spheroplast fusion, of PC12 cells by electroporation and of HeLa and CHO by
`calcium phosphate co-precipitation. For selection of neo transfectants, G418 was
`used at 0.5 mg/ml (PC12), 1 mg/ml (C6) or 2 mg/ml (other cells); gpt+ col-
`onies were selected as described by Mulligan and Berg (1981) for non-lymphoid
`cells and as previously described (Neuberger et al., 1984) for J558L.
`Analysis of RNA
`Total cytoplasmic RNA was prepared as previously described (Neuberger, 1983).
`For heat induction, RNA was extracted 4 h after the cells had been subjected
`to a 2 h shock at 42.5°C. Ribonuclease protection assays were performed as
`described by Melton et al. (1984).
`Analysis of protein
`For biosynthetic labelling of immunoglobulin, cells (5 x 106 in 1 ml) were heat-
`shocked at 42.5°C for 2 h, washed and resuspended in medium containing 5%
`
`2757
`
`Genzyme Ex. 1036, pg 909
`
`

`
`Mulligan,R. and Berg,P. (1981) Proc. Natl. Acad. Sci. USA, 78, 2072-2076.
`Neuberger,M.S. (1983) EMBO J., 2, 1372-1378.
`Neuberger,M.S., Williams,G.T. and Fox,R.O. (1984) Nature, 312, 604-608.
`Neumann,E., Schaefer-Ridder,M., Wang,Y. and Hofschneider,P.H. (1982) EM-
`BO J., 1, 841-845.
`Ochi,A., Hawley,R.G., Shulman,M.J. and Hozumi,N. (1983) Nature, 302,
`340-342.
`Oi,V.T., Morrison,S.L., Herzenberg,L.A. and Berg,P. (1983) Proc. Natl. Acad.
`Sci. USA, 80, 825-829.
`Parkhouse,R.M.E., Askonas,B.A. and Dourmashkin,R.R. (1970) Immunology,
`18, 575-584.
`Pelham,H.R.B. (1982) Cell, 30, 517-528.
`Raju,T.R., Bignami,A. and Dahl,D. (1980) Brain Res., 200, 225-230.
`Reth,M., Imanishi-Kari,T. and Rajewsky,K. (1979) Eur. J. Immunol., 9,
`1004-1013.
`Roth,R.A. and Koshland,M.E. (1981) J. Biol. Chem., 256, 4633-4639.
`Roth,R.A., Mather,E.L. and Koshland,M.E. (1979) In Vogel,H. and Pernis,B.
`(eds), Cells of Immunoglobulin Synthesis. Academic Press, New York,
`pp. 141-151.
`Rubartelli,A., Sitia,R., Zicca,A., Grossi,C.E. and Ferranrini,M. (1983) Blood,
`62, 495-504.
`Sibley,C.H., Ewald,S.J., Kehry,M.R., Douglas,R.H., Raschke,W.C. and
`Hood,L.E. (1980) J. Immunol., 125, 2097-2105.
`Sidman,C. (1981) Cell, 23, 389-397.
`Stott,D.I. (1976) Immunochemistry, 13, 157-163.
`Southern,P.J. and Berg,P. (1982) J. Mol. Appl. Genet., 1, 327-341.
`Vassalli,P., Tartakoff,A., Pink,J.R.L. and Jaton,J.C. (1980) J. Biol. Chem., 255,
`11822-11827.
`Wilde,C.E. and Koshland,M.E. (1978) Biochemistry, 17, 3209-3214.
`Weinheimer,P.F., Mestecky,J. and Acton,R.T. (1971) J. Immunol., 107,
`1211-1212.
`Wood,C.R., Boss,M.A., Kenten,J.H., Calvert,J.E., Roberts,N.A. and Em-
`tage,J.S. (1985) Nature, 314, 446-449.
`Received on May 18, 1987
`Note added in proof
`The secretion of low levels of functional IgG from transfected COS and CHO
`cells has been recently reported [Weidle,U.H., Borgya,A., Mattes,R., Lenz,H.
`and Buckel,P. (1987) Gene, 51, 21-29].
`
`A.Cattaneo and M.S.Neuberger
`
`dialysed FCS, one-tenth the normal concentration of methionine and 50 jCi/ml
`L-[35 S]methionine (1220 Ci/mmol; Amersham International). After a 14-16 h
`incubation at 37°C, cells were collected by centrifugation, washed and lysed in
`0.2 ml PBS/0.5% Nonidet-P40/1 mM phenylmethylsulphonyl fluoride (PMSF).
`For analysis of J chain, the labelling period was shorter (see Figure 6 legend)
`and cells were lysed in 0.1 M Tris-HCI (pH 8.0)/0.1 M KCI/5 mM
`MgCl2/0.5% NP40/1 mM PMSF. When required, tunicamycin (8 pg/ml) was
`included during the heat-shock and labelling periods.
`Immunoprecipitations from culture supernatants or cytoplasmic extracts was
`carried out by incubation with purified rabbit anti-mouse At antiserum (kind gift
`of R.Sitia) or rat monoclonal antibody SM1/45 (kind gift of Y.Argon and
`M.R.Clark), goat anti-mouse X (Miles-Yeda), monoclonal anti-idiotype antibodies
`Ac38 and Ac146 [kind gift of M.Reth (Reth et al., 1979)] or rabbit anti-mouse
`J chain antiserum (kind gift of R.M.E.Parkhouse) followed by precipitation with
`protein A-Sepharose (Pharmacia). After washing with 50 mM Tris-HCI (pH
`7.6)/I M NaCl/0.25% NP40, samples were dissolved in reducing SDS sample
`buffer and analysed by electrophoresis through SDS/polyacrylamide gels (Laemmli,
`1970). Unreduced samples were analysed on 4% acrylamide/0.7%
`N,N'-diallyltartardiamide gels (Pearson et al., 1977). Purification on hapten
`sorbents was carried out using NIP-caproate linked to Sepharose as previously
`described (Neuberger et al., 1984).
`For analysis in the electron microscope (for which we are greatly indebted to
`John Finch), antibody that had been freshly affinity purified on hapten columns
`was concentrated to 1 mg/ml, layered onto carbon films and viewed by negativ

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket